Parathyroid hormone and growth hormone have additive or synergetic effect when used as intervention treatment in ovariectomized rats with established osteopenia.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 10831937)

Published in Bone on June 01, 2000

Authors

L Mosekilde1, L Tornvig, J S Thomsen, P B Orhii, M J Banu, D N Kalu

Author Affiliations

1: Department of Cell Biology, Institute of Anatomy, University of Aarhus, Arhus, Denmark. lm@ana.au.dk

Articles by these authors

Human calcitonin in the treatment of Paget's bone disease. Lancet (1971) 2.37

The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta. J Biol Chem (1999) 1.46

Parathyroid hormone and experimental osteosclerosis. Lancet (1970) 1.42

The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors. Mol Cell Biol (2000) 1.26

Lumbar vertebral body compressive strength evaluated by dual-energy X-ray absorptiometry, quantitative computed tomography, and ashing. Bone (1999) 1.22

DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J Biol Chem (2000) 1.20

Competition between thyroid hormone receptor-associated protein (TRAP) 220 and transcriptional intermediary factor (TIF) 2 for binding to nuclear receptors. Implications for the recruitment of TRAP and p160 coactivator complexes. J Biol Chem (1999) 1.16

Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int (1999) 1.12

Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats. J Bone Miner Res (1990) 0.99

Age- and gender-related differences in vertebral bone mass, density, and strength. J Bone Miner Res (1999) 0.97

The positive effects of zinc on skeletal strength in growing rats. Bone (2001) 0.96

Trabecular bone structure and strength - remodelling and repair. J Musculoskelet Neuronal Interact (2000) 0.96

Effects of exercise and disuse on bone remodeling, bone mass, and biomechanical competence in spontaneously diabetic female rats. Bone (2000) 0.93

In vivo effect of 17 beta-estradiol on intestinal calcium absorption in rats. Bone Miner (1994) 0.92

The effects of gonadectomy on bone size, mass, and volumetric density in growing rats are gender-, site-, and growth hormone-specific. J Bone Miner Res (1999) 0.92

PTH and interactions with bisphosphonates. J Musculoskelet Neuronal Interact (2000) 0.92

Cloning and sequence determination of the gene coding for the elongation factor Tu of Mycobacterium leprae. J Biochem (1994) 0.92

Comparative properties of the nuclear aryl hydrocarbon (Ah) receptor complex from several human cell lines. Eur J Pharmacol (1995) 0.90

Nondestructive determination of iliac crest cancellous bone strength by pQCT. Bone (1997) 0.90

Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone. J Bone Miner Res (1991) 0.89

The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment. Bone (2006) 0.88

Evaluation of the pathogenesis of skeletal changes in ovariectomized rats. Endocrinology (1984) 0.88

Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats. Bone (1995) 0.86

Effects of increased muscle mass on bone in male mice overexpressing IGF-I in skeletal muscles. Calcif Tissue Int (2003) 0.86

Aging and dietary modulation of rat skeleton and parathyroid hormone. Endocrinology (1984) 0.86

Additive effect of voluntary exercise and growth hormone treatment on bone strength assessed at four different skeletal sites in an aged rat model. Bone (1999) 0.86

Lifelong food restriction prevents senile osteopenia and hyperparathyroidism in F344 rats. Mech Ageing Dev (1984) 0.85

Analysis of the effects of growth hormone, voluntary exercise, and food restriction on diaphyseal bone in female F344 rats. Bone (1999) 0.84

A comparison of the effects of two anabolic agents (fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model. Bone (1997) 0.83

Strain differences in bone density and calcium metabolism between C3H/HeJ and C57BL/6J mice. Bone (1999) 0.83

Modulation of intestinal vitamin D receptor by ovariectomy, estrogen and growth hormone. Mech Ageing Dev (1997) 0.83

Vertebral bone density evaluated by dual-energy X-ray absorptiometry and quantitative computed tomography in vitro. Bone (1998) 0.83

Evidence for estrogen receptor-linked calcium transport in the intestine. Bone Miner (1993) 0.82

Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats. Endocrinology (2002) 0.82

Effects of aging and food restriction on the trigeminal ganglion: a morphometric study. Mech Ageing Dev (1992) 0.82

Calcium absorption and bone loss in ovariectomized rats fed varying levels of dietary calcium. Calcif Tissue Int (1999) 0.82

The role of parathyroid hormone in the maintenance of plasma calcium levels in rats. Endocrinology (1974) 0.82

Treatment with risedronate or alendronate prevents hind-limb immobilization-induced loss of bone density and strength in adult female rats. Bone (2000) 0.81

Long-term excessive magnesium supplementation is deleterious whereas suboptimal supply is beneficial for bones in rats. Magnes Res (2000) 0.81

Aged-rodent models of long-term growth hormone therapy: lack of deleterious effect on longevity. J Gerontol A Biol Sci Med Sci (1998) 0.81

Evaluation of a new technique for measuring bone formation. Med Lab Technol (1975) 0.81

Calcium regulatory action of endogenous rat calcitonin demonstrated by passive immunization with calcitonin antibodies. Endocrinology (1980) 0.81

Growth hormone mitigates loss of periosteal bone formation and muscle mass in disuse osteopenic rats. J Musculoskelet Neuronal Interact (2014) 0.81

Effects of ageing on the biomechanical properties of rat articular cartilage. Proc Inst Mech Eng H (2006) 0.81

Effect of calcitonin on (3H)proline incorporation into bone hydroxyproline in the rat. J Endocrinol (1971) 0.81

Putative intestinal estrogen receptor: evidence for regional differences. Mol Cell Endocrinol (1996) 0.81

Male rodent model of age-related bone loss in men. Bone (2001) 0.80

Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly. Eur J Clin Invest (2002) 0.80

Growth hormone and the expression of mRNAs for matrix proteins and oncogenes in bone. Mol Cell Endocrinol (1999) 0.80

Regulation of salivary proteins. J Dent Res (1987) 0.80

Parathyroid hormone increases bone formation and improves mineral balance in vitamin D-deficient female rats. Endocrinology (1997) 0.80

Effects of separate and combined therapy with growth hormone and parathyroid hormone on lumbar vertebral bone in aged ovariectomized osteopenic rats. Bone (2001) 0.79

Lifelong dietary modulation of calcitonin levels in rats. Endocrinology (1983) 0.79

Growth hormone increases vertebral and femoral bone strength in osteopenic, ovariectomized, aged rats in a dose-dependent and site-specific manner. Bone (1998) 0.79

Effect of calcium deprivation on parathyroid hormone-mediated bone and kidney contributions to the maintenance of plasma calcium in rats. J Endocrinol (1975) 0.79

Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats. J Bone Miner Res (2001) 0.79

Three-dimensional microstructural properties of regenerated mineralizing tissue after PTH (1-34) treatment in a rabbit tibial lengthening model. J Musculoskelet Neuronal Interact (2009) 0.79

Analysis of the effects of growth hormone, exercise and food restriction on cancellous bone in different bone sites in middle-aged female rats. Mech Ageing Dev (2001) 0.79

No loss of biomechanical effects after withdrawal of short-term PTH treatment in an aged, osteopenic, ovariectomized rat model. Bone (1997) 0.79

Age-related changes in bone mineral content and density in intact male F344 rats. Bone (2002) 0.78

Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin. J Pineal Res (1994) 0.78

Effects of cerivastatin and parathyroid hormone on the lumbar vertebra of aging male Sprague-Dawley rats. Bone (2002) 0.78

Skeletal growth and long-term bone turnover after enterocystoplasty in a chronic rat model. BJU Int (2003) 0.78

Modulation of intestinal estrogen receptor by ovariectomy, estrogen and growth hormone. J Pharmacol Exp Ther (1998) 0.78

A histomorphometric and scanning electron microscopy study of human condylar cartilage and bone tissue changes in relation to age. Clin Orthod Res (1999) 0.78

Autometallographic tracing of zinc ions in growing bone. J Musculoskelet Neuronal Interact (2004) 0.77

Estrogen modulates the mRNA levels for cancellous bone protein of ovariectomized rats. Bone Miner (1993) 0.77

Evaluation of the role of calcitonin deficiency in ovariectomy-induced osteopenia. Life Sci (1984) 0.77

Influence of a low calcium and phosphorus diet on the anabolic effect of human parathyroid hormone (1-38) in female rats. Bone (2001) 0.77

Effects of ethylenediaminetetraacetate (EDTA) on urinary excretion of hydroxyproline, calcium and phosphorus in the rat. Calcif Tissue Res (1974) 0.77

Effect of transient expression of the oestrogen receptor on constitutive and inducible CYP1A1 in Hs578T human breast cancer cells. Br J Cancer (1996) 0.77

Modulation by food restriction of intracellular calcium signaling in parotid acinar cells of aging Fischer 344 rats. J Gerontol A Biol Sci Med Sci (1997) 0.76

Hypoplasia of bone induced by immobilization. Br J Radiol (1972) 0.76

Age, strain and species differences in circulating parathyroid hormone. Horm Metab Res (1984) 0.76

Bone anabolic effects of separate and combined therapy with growth hormone and parathyroid hormone on femoral neck in aged ovariectomized osteopenic rats. Mech Ageing Dev (2001) 0.75

Evidence for physiological importance of calcitonin in the regulation of plasma calcium in rats. J Clin Invest (1975) 0.75

Alterations in gene expression precede sarcopenia and osteopenia in botulinum toxin immobilized mice. J Musculoskelet Neuronal Interact (2016) 0.75

Anabolic effect of parathyroid hormone on bone in the rat. Calcif Tissue Res (1970) 0.75

Application of design-based stereology for estimation of absolute volume and surface area of the articular and calcified cartilage compartments of undecalcified human femoral heads. J Microsc (2013) 0.75

Acute and longterm effects of thyroidectomy on plasma calcium in rats. Endocrinology (1977) 0.75

Calcitonin. Its physiologic roles. N Y State J Med (1976) 0.75

Acute effect of calcitonin-deficiency on plasma calcium in fasted young rats. Horm Metab Res (1978) 0.75

Further studies on the hypercalcemic effect of acute calcitonin deficiency in rats. Endocrinology (1976) 0.75

Effect of parathyroid hormone on metaphyseal bone in the rat. J Endocrinol (1970) 0.75

Regulation of plasma calcium in rats: age-related roles of PTH and calcitonin. Am J Physiol (1976) 0.75

The effect of enterocystoplasty on bone strength assessed at four different skeletal sites in a rat model. Bone (2003) 0.75

Evidence for the presence of quinone methide isomerase in the metacercarial cyst of Microphallus sp. (Trematoda: Microphallidae). Parasitology (1991) 0.75

Effect of glucagon on bone collagen metabolism in the rat. J Endocrinol (1972) 0.75

Kinetic and metabolic investigations in Paget's disease of bone, assessment of human synthetic calcitonin therapy. Helv Med Acta Suppl (1970) 0.75